Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
21-Oct-2025 | 740.1 | 753.65 | 736 | 750.2 | 4,938 | 10,53,18,142.15 | 91,929 |
23-Oct-2025 | 754.05 | 761.15 | 741.9 | 745.35 | 8,929 | 13,64,50,895.05 | 90,972 |
24-Oct-2025 | 751.3 | 772 | 740.5 | 768.45 | 13,601 | 28,76,09,459.9 | 2,05,842 |
27-Oct-2025 | 777.7 | 784.2 | 762 | 773.15 | 22,202 | 30,18,69,220.45 | 1,77,542 |
28-Oct-2025 | 773.15 | 790 | 770.75 | 784 | 13,575 | 22,10,01,959.85 | 1,52,416 |
29-Oct-2025 | 782.05 | 786 | 768.1 | 773.75 | 5,765 | 12,13,49,940.35 | 94,971 |
30-Oct-2025 | 772.8 | 787 | 772.65 | 775.45 | 5,719 | 11,37,83,770.4 | 68,807 |
31-Oct-2025 | 775.1 | 785.85 | 764.5 | 771.2 | 3,833 | 8,04,33,315 | 58,825 |
03-Nov-2025 | 771.2 | 793 | 768.2 | 773.65 | 7,827 | 17,39,35,064.75 | 1,06,193 |
04-Nov-2025 | 774 | 781.85 | 765 | 766.75 | 6,469 | 14,21,19,587.2 | 1,02,524 |
06-Nov-2025 | 780.05 | 828.9 | 780.05 | 804.85 | 65,064 | 1,85,04,68,143.35 | 5,60,644 |
07-Nov-2025 | 804.85 | 832 | 798 | 822.95 | 23,121 | 70,76,82,709.15 | 3,41,833 |
10-Nov-2025 | 822.95 | 822.95 | 775 | 787.9 | 17,909 | 50,84,46,752.9 | 3,53,614 |
11-Nov-2025 | 785 | 785 | 761 | 765.05 | 8,040 | 16,10,27,933 | 91,357 |
12-Nov-2025 | 766 | 792.9 | 766 | 776.6 | 8,798 | 27,11,19,548.85 | 2,09,018 |
13-Nov-2025 | 776.6 | 806 | 775 | 792.7 | 12,497 | 36,54,30,861.3 | 2,44,071 |
14-Nov-2025 | 792.7 | 792.7 | 772.65 | 780.4 | 6,971 | 14,57,79,219.2 | 87,797 |
17-Nov-2025 | 783 | 799.95 | 779 | 788.15 | 6,970 | 13,72,98,368.35 | 74,941 |
18-Nov-2025 | 788.15 | 803.3 | 781.6 | 797.35 | 7,192 | 15,35,79,910.1 | 70,706 |
19-Nov-2025 | 798.5 | 802.45 | 780.75 | 790.95 | 6,735 | 14,80,30,485.85 | 77,776 |
20-Nov-2025 | 794.75 | 831.9 | 786.5 | 825.75 | 14,154 | 34,63,98,036.9 | 1,92,667 |
Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.
Senores Pharmaceuticals shares closed 6% below their listing price, although they are still up 43% from the IPO price.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
